MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)

DUAL SPECIFIC ANTIBODIES

PREVENTATIVE TREATMENT OF MIGRAINE

METHODS FOR TREATING MUSCLE WASTING AND BONE DISEASE USING NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS

METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE

NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

HETEROCYCLIC GLP-1 AGONISTS

7-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[l,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FORTHEIR USE IN THERAPY

COMBINATION THERAPY FOR TREATING CANCER

POTENT AND SELECTIVE SMARCA2 DEGRADING CHIMERIC MOLECULES AS CANCER THERAPEUTICS

CFTR REGULATORS AND METHODS OF USE THEREOF

BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS

DRUG ELUTING POLYMER COMPOSED OF BIODEGRADABLE POLYMERS APPLIED TO SURFACE OF MEDICAL DEVICE

KIR3DL3 AS AN HHLA2 RECEPTOR, ANTI-HHLA2 ANTIBODIES, AND USES THEREOF

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

NANOENCAPSULATED PHARMACEUTICAL COMPOSITION AND USE THEREOF

METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT

IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES

COMPOSITION BASED ON CROCUS SATIVUS AND CANNABIS SATIVA

COMPOSITIONS COMPRISING NANOPARTICLES, METHOD OF MAKING AND USES THEREOF

COMPOSITIONS AND METHODS FOR ALLEVIATING PULMONARY AILMENTS

METHODS OF TREATING PREDIABETES OR REDUCING THE RISK OF DEVELOPING TYPE 2 DIABETES WITH DAPAGLIFLOZIN

PHARMACEUTICAL COMPOSITIONS COMPRISING (2S)-N-{(1S)-1-CYANO-2-[4-(3-METHYL-2-OXO-2,3-DIHYDRO-1,3-BENZOXAZOL-5-yl)PHENYL]ETHYL}-1,4- OXAZEPANE-2-CARBOXAMIDE

COMBINATION THERAPIES

METHODS FOR TREATING PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA IN CHILDREN, ADOLESCENTS AND ADULTS BY ADMINISTERING (R)-2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXY-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-YL]PIPERIDINE-1-CARBONYL]-4-METHYL-4-[4-(OXETAN-3-YL)PIPERAZIN-1-YL]PENT-2-ENENITRILE

COMPOSITIONS FOR REMOVING SENESCENT CELLS AND USES THEREOF

INHIBITORS OF THE INTERACTION BETWEEN THE ROCK AND PDK1 PROTEIN KINASES

POLYUNSATURATED FATTY ACID MONOGLYCERIDES, COMPOSITIONS, METHODS AND USES THEREOF

TOPICAL DELIVERY OF EDTA COMPOSITIONS

COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION

CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

TOPICAL OCULAR ADMINISTRATION OF AMBROXOL FOR OCULAR PAIN

DRUG DEVICE CONFIGURED FOR WIRELESS COMMUNICATION

INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION

USE OF SPOP MUTATIONS AS A PREDICTIVE BIOMARKER

COMPOSITIONS AND METHODS TO TREAT CANCER

Interferon Production Using Short RNA Duplexes

siRNAs and shRNAs Targeting HIV and Combinations, Expression Cassettes, Cells and Use Thereof

ANAPLASTIC LYMPHOMA KINASE ANTIBODIES AND METHODS OF USE THEREOF

MULTISPECIFIC BINDING MOLECULES COMPRISING LTBR AND EDB BINDING DOMAINS AND USES THEREOF

METHOD OF TREATING IGA NEPHROPATHY BY ADMINISTERING ALTERED ANTIBODIES WHICH BIND HUMAN A PROLIFERATION-INDUCING LIGAND (APRIL) PROTEIN

ANTIBODIES SPECIFICALLY RECOGNIZING FASL AND USES THEREOF

METHODS OF TREATING UREA CYCLE DISORDERS BY INTERFERING WITH GLUCAGON RECEPTOR SIGNALING

METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE

METHODS TO ENHANCE THERAPEUTIC EFFICACY IN MELANOMA VIA MODULATION OF CELL SURFACE PD-L1/L2

ANTI-TREM2 ANTIBODIES AND METHODS OF USE

METHODS, COMPOSITIONS AND DOSING REGIMENS FOR TREATING OR PREVENTING INTERFERON-GAMMA RELATED INDICATIONS

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

MODIFIED T CELLS AND USES THEREOF

KRAS INHIBITORS

PEPTIDYL NITRILE COMPOUND AND USE THEREOF

1,3-BENZODIOXOLE ESTERS AND THEIR THERAPEUTIC USE

BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS

Cis-substituted 5-(hydroxymethyl)morpholine-2-carboxamides as agonists of SSTR4

POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

MULTIPLE SIGN BIT HIDING WITHIN A TRANSFORM UNIT

TREATMENT OF PATIENTS DIAGNOSED WITH PANCREATIC DUCTAL ADENOCARCINOMA USING MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS WITH IMMUNE CHECKPOINT INHIBITORS AND MHC CLASS I ACTIVATORS

COMPOUND FOR USE IN PREVENTING AND/OR TREATING AN INFECTION CAUSED BY SARS-COV-2

Natural Preservatives and Antimicrobial Agents, Including Compositions Thereof

Ophthalmic formulations and methods of use

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DEMYELINATING DISEASES CONTAINING SUPERNATANT OF IMMORTALIZED MESENCHYMAL STEM CELLS, AND PHARMACEUTICAL PREPARATION CONTAINING SAME COMPOSITION AS ACTIVE INGREDIENT

STRONTIUM BASED COMPOSITIONS AND FORMULATIONS FOR PAIN, PRURITUS, AND INFLAMMATION

WOUND HEALING MEDICAMENT

THERAPEUTIC COMPOUNDS

PLASMA KALLIKREIN INHIBITORS

TREATMENT OF MITOCHONDRIAL DISEASES

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

ORGANIC COMPOUNDS

REMIBRUTINIB FOR USE IN THE TREATMENT OF HIDRADENITIS SUPPURATIVA

Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor

HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS

SOLID FORMS OF BERBERINE URSODEOXYCHOLATE AND COMPOSITIONS AND METHODS THEREOF

Methods for Sensitizing Gliomas to Immunotherapy

Methods of Treating a Subject for Long-Haul COVID-19, and Compositions for Use in the Same

A PHARMACEUTICAL COMBINATION AND USE THEREOF

REGIMEN FOR SUPPRESSING ORGAN REJECTION

SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS

GLP-1R MODULATING COMPOUNDS

Indolium Compounds for Treating Cancer

SMALL MOLECULE MODULATORS OF GPR139 COMPLEX

COMPOSITIONS COMPRISING THEANINE, MAGNOLIA, AND PHELLODENDRON

Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

IMPROVED SURAMIN METHODS AND COMPOSITIONS

TREATING CANCERS WITH COMBINATIONS OF ACYLFULVENES WITH IBRUTINIB AND/OR BORTEZOMIB

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

Extended Release Boswellic Acid and Manufacturing Thereof

FLEECE FOR POUCHED PRODUCT WITH CONTROLLED BASIS WEIGHT

METHOD AND SYSTEM FOR DISTRACTION NEUROGENESIS

BIOMARKERS AND METHODS OF TREATING PD-1 AND PD-L1 RELATED CONDITIONS

MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)

BIOMARKERS FOR CANCER THERAPY

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

COMBINATION THERAPY FOR TREATING HEPATITIS B VIRUS INFECTIONS

HUMAN ANTIBODIES TO PD-L1

IL-4/IL-13 Pathway Inhibitors for Enhanced Efficacy in Treating Cancer

METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS

NKG2D-FC FOR IMMUNOTHERAPY

Multimeric T-Cell Modulatory Polypeptides and Methods of Use Thereof

ANTIMICROBIAL TYPE-II BACTERIOCINS

DEGRADABLE POLYMERS OF A CYCLIC SILYL ETHER AND USES THEREOF

MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE

HETEROARYL SUBSTITUTED SPIROPIPERIDINYL DERIVATIVES AND PHARMACEUTICAL USES THEREOF

ISOCITRATE DEHYDROGENASE 1 INHIBITORS AND METHODS OF USE THEREOF

NOVEL AND HIGHLY SELECTIVE SARS-COV-2 MPRO INHIBITORS

IDO/TDO Inhibitor

COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE

GSPT1 COMPOUNDS AND METHODS OF USE OF THE NOVEL COMPOUNDS

SALTS AND SOLID FORMS OF N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE

ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE

GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

METHODS OF INHIBITING CEREBRAL INFLAMMATION

CYCLOSPORINE FORMULATIONS FOR USE IN THE TREATMENT OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS)

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

COMBINATION FOR USE FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME

MULTIVITAMIN FOR AUXILIARY REGULATION OF BLOOD PRESSURE AND PREPARATION METHOD AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR PROMOTING DEVELOPMENT OF INFANT

FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY

AMMONIA OXIDIZING MICROORGANISMS FOR THE REGULATION OF BLOOD PRESSURE

THERAPEUTIC USE OF FIBROBLASTS TO STIMULATE THE IMMUNE SYSTEM

GENETICALLY ENGINEERED CELLS HAVING ANTI-CD133 / ANTI-EGFR CHIMERIC ANTIGEN RECEPTORS, AND USES THEREOF

METHODS FOR TREATING NONTUBERCULOUS MYCOBACTERIA DISEASES

5-FU AND RNAOG COMBINED IMMUNOCHEMOTHERAPY FOR PANCREATIC CANCER TREATMENT

Compositions and Methods for Inhibiting and Treating Coronavirus Infections

BUDESONIDE 21-PHOSPHATE SODIUM SALT FOR USE AS ANTI-INFLAMMATORY OR ANTIASTHMATIC AGENT

J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS FOR SKIN AND/OR ORAL DISORDERS

METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES

SHP2 INHIBITOR COMPOSITIONS AND METHODS FOR TREATING CANCER

LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF

DOSING REGIMEN OF HIV CAPSID INHIBITOR

COMBINATION THERAPY FOR THE TREATMENT OF MASTOCYTOSIS

SMALL MOLECULE PEPTIDOMIMETIC FOR THE TREATMENT OF TAUOPATHIES

COMPOUNDS USEFUL AS KINASE INHIBITORS

COMPOSITIONS AND METHODS FOR IMPROVING BONE HEALTH USING SELF-EMULSIFYING FORMULATIONS OF DIINDOLYLMETHANE

METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

LASOFOXIFENE TREATMENT OF BREAST CANCER

Methods And Kits For Treating Fever In Children With Combined Ibuprofen And Acetaminophen

Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib

UNIQUE ANALOGS OF NATURAL LIGNANS USEFUL FOR TREATING TRIPLE NEGATIVE BREAST CANCER

Macrophage Targeted Immunotherapeutics

LIPID COMPOUND AND PREPARATION METHOD THEREFOR, AND USE THEREOF

CELL-WALL BINDING PROTEIN SPECIFICALLY TARGETING CUTIBACTERIUM ACNES

Neurosome/Astrosome Compositions and Methods of Use

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR PHARMACEUTICAL COMPOSITIONS

SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS

INNOVATIVE DELIVERY SYSTEM DEVICE AND METHOD FOR PHARMACEUTICAL IMPLANTATION FOR TIMED RELEASE

FORMULATIONS AND DOSES OF PEGYLATED URICASE

GENERATION OF HUMAN ALLERGEN- AND HELMINTH-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

METHODS FOR TREATING MYOSITIS USING FCRN ANTAGONISTS

COMPOSITIONS AND METHODS FOR MODULATING LAIR SIGNAL TRANSDUCTION

Advanced Avatar Dendritic Cells

Method of Redirecting T Cells to Treat HIV Infection

RNA ENCODING A THERAPEUTIC PROTEIN

FUSED-RING AMINE DERIVATIVE

INHIBITORS OF SARS-COV-2

SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY

PHENYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

GLP-1R MODULATING COMPOUNDS

CRYSTALLINE FORMS OF C21H22Cl2N4O2

PHENYLPYRAZOLE COMPOUND AND APPLICATION THEREOF

SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS

ALGINIC ACID-BASED INJECTABLE HYDROGEL SYSTEM

METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST

ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS FOR TREATING ENTERIC DISEASES IN ANIMALS

TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH EXENDIN (9-39)

CXCL14-BASED COMPOSITIONS AND METHOD FOR ENHANCING CARTILAGE REGENERATION

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

ISOCYCLOSPORIN A FOR TOPICAL TREATMENT OF OCULAR DISEASES

REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION

COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY

METHODS FOR ATTENUATING VIRAL INFECTION AND FOR TREATING LUNG INJURY

SYSTEMS OF ENGINEERED RECEPTORS TARGETING PSMA AND CA9

BIOAVAILABLE MIXTURE PROVIDING SAFE, BROAD-SPECTRUM, ANTIPATHOGENIC, HEALTH, FITNESS, NEUROLOGICAL, AND HOMEOSTATIC BENEFITS

MANNO-OLIGOSACCHARIDE COMPOSITIONS FOR PATHOGEN CONTROL

AZD3355 (LESOGABERAN) FOR TREATMENT AND PREVENTION OF NONALCOHOLIC STEATOHEPATITIS (NASH), LIVER FIBROSIS, AND OTHER LIVER CONDITIONS

COMBINED USE OF MULTIKINASE INHIBITOR

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

Therapeutics for Hyponatremia and Polycystic Kidney Disease

Dosing Regime For Treatment of Chronic Hand Eczema

ANTIPROLIFERATIVE COMPOUNDS AND SECOND ACTIVE AGENTS FOR COMBINED USE

NOVEL THERAPY

NOVEL CINNAMAMIDE DERIVATIVES AND USE THEREOF

METHODS OF USING RAD51 INHIBITORS FOR TREATMENT OF PANCREATIC CANCER

Methods for Administration and Methods for Treating Cardiovascular Diseases with Resiniferatoxin

METHOD FOR TREATING TAUOPATHY IN THE BRAIN, BRAIN STEM AND SPINAL COLUMN

TREATMENT OR PREVENTION OF CARDIOVASCULAR EVENTS VIA THE ADMINISTRATION OF A COLCHICINE DERIVATIVE

Method Of Treating Major Depressive Disorder

Tamper resistant dosage forms

CATIONIC LIPID COMPOUND, COMPOSITION CONTAINING SAME AND USE THEREOF

TOPICAL FORMULATIONS FOR HANDLING ATOPIC DERMATITIS

COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE

METHODS FOR SELECTING A CANCER PATIENT FOR TREATMENT

EPIGENTIC REGULATION AND CO-TARGETING APPROACHES OF PSMA IN PROSTRATE CANCER

Treatment Of Muscle Disorder With Folliculin Interacting Protein 1 (FNIP1) Inhibitors And/Or Folliculin (FLCN) Inhibitors

Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells

MULTIFUNCTIONAL MOLECULES AND USES THEREOF

BI-SPECIFIC ANTIBODIES AND USE THEREOF

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

COMBINATION THERAPY WITH DEXAMETHASONE AND TUMOR-SPECIFIC T CELL ENGAGING MULTI-SPECIFIC ANTIBODIES FOR TREATING CANCER

STABLE GLP-1 ANALOGS FOR THE TREATMENT OF HUMAN DISEASE AND DISORDERS

Heteroaryl compounds as inhibitors of irak4, compositions and applications thereof

MACROCYCLIC BTK INHIBITORS

A2-ADRENOCEPTOR SUBTYPE C ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA

CARBONYL BRIDGED HETEROCYCLIC COMPOUND, AND COMPOSITION AND APPLICATION THEREOF

METHODS AND COMPOSITIONS FOR TREATMENT OF PREECLAMPSIA AND CANCER

CONJUGATE COMPOUNDS AND COMPOSITIONS

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS

MITAPIVAT THERAPY AND MODULATORS OF CYTOCHROME P450

CHOLINE ACETYLTRANSFERASE AS A THERAPY FOR ENDOTOXEMIA, SEPSIS, COLITIS AND INFLAMMATORY DISEASES

THERAPY FOR PROMOTING CELL GROWTH

PHARMACEUTICAL COMPOSITION CONTAINING BACTERIA

CORYNEBACTERIUM TO TREAT OR LIMIT CUTANEOUS WOUND INFECTION

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION

METHODS AND COMPOSITIONS FOR TREATMENT OF PENILE DEFECTS

THERAPEUTIC AGENT-LOADED TISSUES FOR CORNEAL TRANSPLANT

NITRITE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS

AMINO ACID FORMULATIONS AND USES THEREOF

NEW TREATMENT

INHIBITION OF MAST CELL TUMOR NECROSIS FACTOR FOR THERAPEUTIC USE

COMBINATION THERAPIES INCLUDING PARP1 INHIBITORS

MODULATORS OF RAR-RELATED ORPHAN RECEPTORS (RORs)

GENETICALLY ENGINEERED DRUG RESISTANT T CELLS AND METHODS OF USING THE SAME

USE OF GLUCOCORTICOID RECEPTOR MODULATORS TO POTENTIATE CHECKPOINT INHIBITORS

TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST

METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES

COVALENT TARGETING OF RhoA FOR CANCER THERAPY

IL-6 AND/OR IL-1BETA INHIBITOR

ANALOGS OF CYCLOBENZAPRINE AND AMITRYPTILENE

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

RXR AGONISTS IN EYE DISORDERS

Diagnosis and Treatment of Vitiligo

FORMULATIONS COMPRISING A THERAPEUTIC PROTEIN AND AT LEAST ONE STABILIZER

TAMPER RESISTANT DOSAGE FORMS

METHODS FOR IDENTIFYING ADAR1 INHIBITORS, AND COMPOSITIONS AND METHODS OF USE IN TREATING CANCER

DETECTION OF GENETIC VARIANTS OF THE BETA-ADRENERGIC RECEPTOR PATHWAY FOR DETECTING AND TREATING RETINOPATHY OF PREMATURITY

Application of PRDX5 and GPX4 Genes in Preparation of Drugs for Castration-resistant Prostate Cancer

RNA INTERFERENCE MEDIATED INHIBITION OF PROLYL HYDROXYLASE DOMAIN 2 (PHD2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)

METHODS AND MATERIALS FOR TREATING HEART ATTACK

METHODS OF TREATING CANCER WITH A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE

BISPECIFIC ANTIBODIES AGAINST HER2

CELL INJURY INDUCING THERAPEUTIC DRUG FOR USE IN CANCER THERAPY

Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

METHODS OF TREATING AGE-RELATED AND INFLAMMATORY DISEASES

AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

Anti-B7-H4 Chimeric Antigen Receptor-Modified NK-92 Cells

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

Gamma Delta T-Cell-Binding Polypeptides and Uses Thereof

C-KIT ANTIBODIES

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

LIPOSOME ENCAPSULATED AFFINITY DRUG

NUCLEIC ACID MOLECULES ENCODING ANTIBODIES TO A PROLIFERATION-INDUCING LIGAND (APRIL)

SYNTHETIC AMPHIPATHIC HELICAL PEPTIDES AND TREATMENT METHODS USING SYNTHETIC AMPHIPATHIC HELICAL PEPTIDES

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS

ANTIMALARIAL AGENTS

Pyrimidine-Annulated Triazole Derivatives and Their Use in Platelet Aggregation Inhibition

SOMATOSTATIN RECEPTOR SUBTYPE 5 ANTAGONISTS, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

COMPOUNDS AND USES THEREOF

Amorphous Form of (S)-2-(5-((3-Ethoxypyridin-2-YL)Oxy)Pyridin-3-YL)-N-(Tetrahydrofuran-3-YL)Pyrimidine-5-Carboxamide

PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN

CRYSTALLINE FORMS OF A COMPOUND FOR TREATING OR PREVENTING GOUT OR HYPERURICEMIA

SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE

DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE

Sodium thiosulfate-containing pharmaceutical compositions

COMPOUNDS SPECIFIC TO GRANZYME B AND USES THEREOF

ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

ARTIFICIAL OXYGEN CARRIER BLOOD PRODUCT

COMPOSITIONS AND METHODS FOR INHIBITION OF HAO1 (HYDROXYACID OXIDASE 1 (GLYCOLATE OXIDASE)) GENE EXPRESSION

COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF

HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS

ANTI-TIGIT ANTIBODIES

MULTICOMPONENT CHEMICAL COMPOSITION OF A PEPTIDE-BASED NEOANTIGEN VACCINE

USE OF LYSIN TO RESTORE/AUGMENT ANTIBACTERIAL ACTIVITY IN THE PRESENCE OF PULMONARY SURFACTANT OF ANTIBIOTICS INHIBITED THEREBY

COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORM

COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT

POSTBIOTIC COMPOSITIONS AND METHODS

SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF

METHOD FOR PREVENTING OR TREATING MUSCLE DISEASE

METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND VASCULOGENESIS

TRACE ELEMENTS

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES

TARGET PROTEIN DEGRADATION COMPOUNDS, THEIR ANTI-TUMOR USE, THEIR INTERMEDIATES AND USE OF INTERMEDIATES

COMPOSITIONS AND METHODS FOR TREATING CLOSTRIDIOIDES DIFFICILE INFECTIONS

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF DISEASES UTILIZING TIRILAZAD SALTS

NASAL COMPOSITIONS COMPRISING ALCAFTADINE

Nasal compositions comprising alcaftadine

NASAL COMPOSITIONS COMPRISING ALCAFTADINE

NASAL COMPOSITIONS COMPRISING ALCAFTADINE

THIADIAZINE DERIVATIVES

SELECTIVE TREATMENT OF CANCERS HAVING HISTONE H3 MUTATIONS OR ABERRANT LEVELS OF DNA OR HISTONE METHYLATION, ACETYLATION OR DEFECTS IN HOMOLOGOUS RECOMBINATION